These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33669308)

  • 1. Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson's Disease.
    Surguchov A
    Cells; 2021 Feb; 10(2):. PubMed ID: 33669308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson's Disease.
    Ma C; Feng Y; Li X; Sun L; He Z; Gan J; He M; Zhang X; Chen X
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):127-144. PubMed ID: 36637699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic rescue of α-synuclein-induced neurodegeneration through propionate supplementation and intestine-neuron signaling in C. elegans.
    Wang C; Yang M; Liu D; Zheng C
    Cell Rep; 2024 Mar; 43(3):113865. PubMed ID: 38412096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
    Wei CC; Chang CH; Liao VH
    Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
    Vargas JY; Grudina C; Zurzolo C
    Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease.
    Lashuel HA; Hirling H
    ACS Chem Biol; 2006 Aug; 1(7):420-4. PubMed ID: 17168518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
    Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
    Zhang S; Glukhova SA; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2017 Oct; 26(19):3823-3836. PubMed ID: 28934392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
    Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
    Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease.
    Kim JB; Kim Y; Kim SJ; Ha TY; Kim DK; Kim DW; So M; Kim SH; Woo HG; Yoon D; Park SM
    J Neuroinflammation; 2024 Feb; 21(1):53. PubMed ID: 38383441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Parkinson's disease in adult Drosophila.
    Dabool L; Juravlev L; Hakim-Mishnaevski K; Kurant E
    J Neurosci Methods; 2019 Jan; 311():89-94. PubMed ID: 30336223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
    Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
    Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease.
    Harrington AJ; Hamamichi S; Caldwell GA; Caldwell KA
    Dev Dyn; 2010 May; 239(5):1282-95. PubMed ID: 20108318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic stress induced toxicity exacerbates Parkinson's associated effects via dysregulation of autophagy in transgenic C. elegans model.
    Jadiya P; Mir SS; Nazir A
    Cell Signal; 2018 May; 45():71-80. PubMed ID: 29410282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein Trafficking in Parkinson's Disease: Insights From Fly and Mouse Models.
    Cheng J; Lu Q; Song L; Ho MS
    ASN Neuro; 2018; 10():1759091418812587. PubMed ID: 30482039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.